T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer

    NEXT STORY
    Turning Point Therapeutics Announces Management Transition
    PREV STORY
    Chembio Diagnostics Announces CEO Transition
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

    author_avatar
    NASDAQ Market News

    Clinical Trial Supplies Market Research Report by Services, by Type, by Phase, by Therapeutic Area, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19

    author_avatar
    NASDAQ Market News

    Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19

    author_avatar
    NASDAQ Market News